TY - JOUR
T1 - Switch or swap strategy in rheumatoid arthritis patients failing TNF inhibitors? Results of a modified Italian Expert Consensus
AU - Todoerti, Monica
AU - Favalli, Ennio Giulio
AU - Iannone, Florenzo
AU - Olivieri, Ignazio
AU - Benucci, Maurizio
AU - Cauli, Alberto
AU - Mathieu, Alessandro
AU - Santo, Leonardo
AU - Minisola, Giovanni
AU - Lapadula, Giovanni
AU - Bucci, Romano
AU - Gremese, Elisa
AU - Caporali, Roberto
PY - 2018
Y1 - 2018
N2 - Objective: To establish evidence-based and experts' opinion filtered statements on the optimal treatment choice between cycling (switch) and changing mode of action strategies (swap) in RA patients failing TNF inhibitors (TNFis).Methods: The relevant question (switch vs swap) was rephrased into a research question according to the population, intervention, comparison and outcome (PICO) strategy, considering all the available scientific evidence published from the 2013 EULAR set of recommendations up to mid-January 2016. Final statements derived from the retrieved scientific evidence and experts' consensus, with eventual rephrasing through a Delphi method during a national consensus of Italian rheumatologists.Results: From a total of 365 records, 12 studies were finally included. The final statements argued that, until head-to-head comparison data are available, switch and swap can be still considered suitable strategies in RA patients failing first TNFi, even though some data seem to lend more support to a different mode of action-targeted strategy.Conclusion: After failure of first TNFi course, switch and swap can be currently considered as alternative suitable approaches in RA patients.
AB - Objective: To establish evidence-based and experts' opinion filtered statements on the optimal treatment choice between cycling (switch) and changing mode of action strategies (swap) in RA patients failing TNF inhibitors (TNFis).Methods: The relevant question (switch vs swap) was rephrased into a research question according to the population, intervention, comparison and outcome (PICO) strategy, considering all the available scientific evidence published from the 2013 EULAR set of recommendations up to mid-January 2016. Final statements derived from the retrieved scientific evidence and experts' consensus, with eventual rephrasing through a Delphi method during a national consensus of Italian rheumatologists.Results: From a total of 365 records, 12 studies were finally included. The final statements argued that, until head-to-head comparison data are available, switch and swap can be still considered suitable strategies in RA patients failing first TNFi, even though some data seem to lend more support to a different mode of action-targeted strategy.Conclusion: After failure of first TNFi course, switch and swap can be currently considered as alternative suitable approaches in RA patients.
KW - Antirheumatic Agents
KW - Consensus
KW - Delphi Technique
KW - Evidence-Based Medicine
KW - Humans
KW - Italy
KW - Pharmacology (medical)
KW - Rheumatoid Arthritis
KW - Rheumatology
KW - Tumor Necrosis Factor-alpha
KW - Antirheumatic Agents
KW - Consensus
KW - Delphi Technique
KW - Evidence-Based Medicine
KW - Humans
KW - Italy
KW - Pharmacology (medical)
KW - Rheumatoid Arthritis
KW - Rheumatology
KW - Tumor Necrosis Factor-alpha
UR - https://publicatt.unicatt.it/handle/10807/132766
UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85054467704&origin=inward
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85054467704&origin=inward
U2 - 10.1093/rheumatology/key195
DO - 10.1093/rheumatology/key195
M3 - Article
SN - 1462-0332
VL - 57
SP - vii42-vii53
JO - Rheumatology
JF - Rheumatology
IS - 57
ER -